APA (7th ed.) Citation

Vasanti Suvarna, Kajal Deshmukh, & Manikanta Murahari. (2022). miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Vasanti Suvarna, Kajal Deshmukh, and Manikanta Murahari. MiRNA and Antisense Oligonucleotide-based α-synuclein Targeting as Disease-modifying Therapeutics in Parkinson's Disease. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Vasanti Suvarna, et al. MiRNA and Antisense Oligonucleotide-based α-synuclein Targeting as Disease-modifying Therapeutics in Parkinson's Disease. Frontiers Media S.A., 2022.